Cargando…

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis

BACKGROUND: Pancreatic cancer is a highly lethal disease with a poor prognosis while metformin has been associated with a decreased risk of pancreatic cancer. Although the benefit of metformin was observed for pancreatic cancer prevention, it is not clear whether it can also affect the survival of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ping-Ting, Li, Bo, Liu, Fu-Rao, Zhang, Mei-Chao, Wang, Qian, Li, Yan-Yan, Xu, Ci, Liu, Yuan-Hua, Yao, Yuan, Li, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421925/ https://www.ncbi.nlm.nih.gov/pubmed/28445955 http://dx.doi.org/10.18632/oncotarget.15692

Ejemplares similares

Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
por: Zhang, Junqiang, et al.
Publicado: (2020)

The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
por: Li, Xiaogang, et al.
Publicado: (2017)

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017)

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014)

Metformin therapy associated with survival benefit in lung cancer patients with diabetes
por: Wan, Guoxing, et al.
Publicado: (2016)

Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis
por: Jiao, Yu, et al.
Publicado: (2022)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis
por: Yao, Xiangyang, et al.
Publicado: (2021)

The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017)

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
por: Li, Yang, et al.
Publicado: (2017)

Predictive value of drain pancreatic amylase concentration for postoperative pancreatic fistula on postoperative day 1 after pancreatic resection: An updated meta-analysis
por: Liu, Yao, et al.
Publicado: (2018)

Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Publicado: (2014)

Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017)

The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)

Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
por: Yan, Ting-Ting, et al.
Publicado: (2015)

Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic Cancer: A Retrospective Cohort Study
por: Chen, Yang, et al.
Publicado: (2022)

Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
por: Tang, Yun-Liang, et al.
Publicado: (2017)

Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
por: Fang, Yuan, et al.
Publicado: (2019)

The Clinical Effect of Metformin on the Survival of Lung Cancer Patients with Diabetes: A Comprehensive Systematic Review and Meta-analysis of Retrospective Studies
por: Cao, Xun, et al.
Publicado: (2017)

The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis
por: Lin, Zhuang-Bin, et al.
Publicado: (2020)

Compromised autophagy by MIR30B benefits the intracellular survival of Helicobacter pylori
por: Tang, Bin, et al.
Publicado: (2012)

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
por: Forouzandeh, Farshad, et al.
Publicado: (2014)

Nasogastric or nasojejunal feeding in predicted severe acute pancreatitis: a meta-analysis
por: Chang, Yu-sui, et al.
Publicado: (2013)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
por: Toomey, Paul, et al.
Publicado: (2017)

Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study
por: Shi, Ping, et al.
Publicado: (2021)

Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis
por: Yang, Ting, et al.
Publicado: (2015)

Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer
por: Yang, Xue, et al.
Publicado: (2015)

Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series
por: Zhao, Li, et al.
Publicado: (2022)

Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Effects of food on pharmacokinetics and safety of metformin hydrochloride tablets: A meta-analysis of pharmacokinetic, bioavailability, or bioequivalence studies
por: Sun, Ming-Li, et al.
Publicado: (2023)

Metformin and Its Benefits for Various Diseases
por: Lv, Ziquan, et al.
Publicado: (2020)

Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis
por: Zhang, Hai-Chao, et al.
Publicado: (2018)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
por: Chen, Ke, et al.
Publicado: (2017)

Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data
por: Qi, Wei-Xiang, et al.
Publicado: (2013)

Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
por: Shi, Yu-Qi, et al.
Publicado: (2020)

Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
por: Hou, Yi-Chao, et al.
Publicado: (2016)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma: erratum
Publicado: (2017)

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
por: Vernieri, Claudio, et al.
Publicado: (2019)

BAG3‐positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma
por: Yuan, Ye, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k3cb6s2053nfukhqpfnme2pgnu